Write in a clean editor, then format for Diabetology & Metabolic Syndrome in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Diabetology & Metabolic Syndrome is a peer-reviewed journal published by BMC (BioMed Central), covering Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Diabetes Management and Research. Over its lifetime it has published 2,904 papers, which have received 59,126 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Diabetology & Metabolic Syndrome. 2023;12(3):45–58.
Formats any DOI in Diabetology & Metabolic Syndrome style. No sign-up. |
| Publishes research in | Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Treatment and Management Diabetes Management and Research Adipokines, Inflammation, and Metabolic Diseases Hyperglycemia and glycemic control in critically ill and hospitalized patients |
| ISSN | 1758-5996 |
| Citation impact (2-yr) | 4.71 |
| h-index | 100 |
| i10-index | 1,372 |
| Article processing charge | $2,195 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Universidade de São Paulo |
| Journal website | link.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: The prevalence of non-alcoholic fatty liver disease (NAFLD) has been increasing rapidly. It is nowadays recognized as the most frequent liver disease, affecting a quarter of global population and regularly coexisting with metabolic disorders such as type 2 diabetes, hypertension, obesity, and cardiovascular disease. In a more simplistic view, NAFLD could be defined as…
The management of T2DM requires aggressive treatment to achieve glycemic and cardiovascular risk factor goals. In this setting, metformin, an old and widely accepted first line agent, stands out not only for its antihyperglycemic properties but also for its effects beyond glycemic control such as improvements in endothelial dysfunction, hemostasis and oxidative stress, insulin resistance,…
BACKGROUND: Obesity has become a leading global health problem owing to its strong association with a high incidence of diseases. AIM: To induce rat obesity using high fat diet (HFD) and to estimate oxidative stress markers in their liver, heart and kidney tissues in order to shed the light on the effect of obesity on…
High plasma uric acid (UA) is a precipitating factor for gout and renal calculi as well as a strong risk factor for Metabolic Syndrome and cardiovascular disease. The main causes for higher plasma UA are either lower excretion, higher synthesis or both. Higher waist circumference and the BMI are associated with higher insulin resistance and…
BACKGROUND: Metabolic syndrome over the years have structured definitions to classify an individual with the disease. Literature review suggests insulin résistance is hallmark of these metabolic clustering. While measuring insulin resistance directly or indirectly remains technically difficult in general practice, along with multiple stability issues for insulin, various indirect measures have been suggested by authorities.…
Infectious Diseases of Poverty
International Journal of Emergency Medicine
Journal of Anesthesia, Analgesia and Critical Care
Journal of Cardiothoracic Surgery
Journal of Health, Population and Nutrition
Journal of NeuroEngineering and Rehabilitation
Frontiers in Earth Science
Frontiers in Electronics
